—

Medacta Group SA(MOVE.SW)— 同業公司組

數據截至2026-10-12 — 評分每個交易日晚間重新計算。分組標準=首先為共同的Closelook指數成分,其次為產業。Closelook研究日記,不構成投資建議。

Medacta Group SA的Closelook綜合評分為47/100,在同業公司組內排名第10位(共11家)——組內評分最高的是DexCom Inc(66/100)。

名稱綜合動能品質估值訊號距52週高點
MOVE.SW Medacta Group SA47125731warn35.1%
DXCM DexCom Inc66858035bull9.2%
GMED Globus Medical60326457bear26.4%
SECT-B.ST Sectra AB (publ)60836611bull6.7%
SNN Smith & Nephew SNATS Inc56245573warn25.1%
SOON.SW Sonova H Ag56927250bull0.3%
CEVI.ST CellaVision AB55736929watch13.9%
YPSN.SW Ypsomed Holding AG56696228info13.7%
BANB.SW Bachem Holding AG50754032ok3.8%
TECN.SW Tecan Group AG48932752ok7.7%
GALE.SW Galenica Sante AG44382962info16.6%

評分為Closelook全部涵蓋範圍內的相對讀數——方法論詳見公司評分說明。訊號燈來自每日夜間訊號看板。

FAQ · from the current data · as of 2026-10-12

Quick answers

Medacta Group SA在Closelook涵蓋範圍內的同業公司有哪些?

分組首先根據共同的Closelook指數成分,其次根據產業:DexCom Inc (DXCM)、Globus Medical (GMED)、Sectra AB (publ) (SECT-B.ST)、Smith & Nephew SNATS Inc (SNN)、Sonova H Ag (SOON.SW)、CellaVision AB (CEVI.ST)、Ypsomed Holding AG (YPSN.SW)、Bachem Holding AG (BANB.SW)等。

MOVE.SW相對同業公司的評分如何?

Medacta Group SA的綜合評分為47/100,組內排名第10位(共11家),截至2026-10-12;組內最高綜合評分為DexCom Inc(66/100)。Closelook評分為研究日記讀數,不構成評等或投資建議。

Related in the Closelooknet universe

then Medical Devices. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.